About Glycine receptor subunit alpha-1
Glycine receptor subunit alpha-1 (GLRA1) is a protein
from Homo sapiens identified by UniProt accession
P23415, 457 residues long.
MolForge cross-references it against 0 known binders and
393 disease associations.
Target properties
| Protein name | Glycine receptor subunit alpha-1 |
| UniProt accession | P23415 |
| Gene | GLRA1 |
| Organism | Homo sapiens |
| Length | 457 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (16)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (393)
Diseases linked to this target (Open Targets).
- hereditary hyperekplexia · score 0.74
- pain · score 0.58
- delirium · score 0.56
- Agitation · score 0.55
- coronary artery disease · score 0.55
- ischemia reperfusion injury · score 0.54
- kidney failure · score 0.53
- acute respiratory distress syndrome · score 0.52
- post operative nausea and vomiting · score 0.50
- hypotension · score 0.50
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P23415-F1 | alphafold | PREDICTED | 83.99 | — |
Amino-acid sequence (457 residues)
MYSFNTLRLY LWETIVFFSL AASKEAEAAR SAPKPMSPSD FLDKLMGRTS GYDARIRPNF KGPPVNVSCN IFINSFGSIA ETTMDYRVNI FLRQQWNDPR LAYNEYPDDS LDLDPSMLDS IWKPDLFFAN EKGAHFHEIT TDNKLLRISR NGNVLYSIRI TLTLACPMDL KNFPMDVQTC IMQLESFGYT MNDLIFEWQE QGAVQVADGL TLPQFILKEE KDLRYCTKHY NTGKFTCIEA RFHLERQMGY YLIQMYIPSL LIVILSWISF WINMDAAPAR VGLGITTVLT MTTQSSGSRA SLPKVSYVKA IDIWMAVCLL FVFSALLEYA AVNFVSRQHK ELLRFRRKRR HHKSPMLNLF QEDEAGEGRF NFSAYGMGPA CLQAKDGISV KGANNSNTTN PPPAPSKSPE EMRKLFIQRA KKIDKISRIG FPMAFLIFNM FYWIIYKIVR REDVHNQ
Explore Glycine receptor subunit alpha-1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets